Literature DB >> 21989974

[Parathyroid dysfunction and rheumatic manifestations].

D P Frey1.   

Abstract

Parathyroid dysfunction, leading to severe clinical symptoms and radiographic changes, has decreased over the last years due to routine laboratory checks including serum calcium levels. Thus, abnormal calcium levels are detected early in the course of the disease and the underlying cause treated accordingly. Hyperparathyroidism often leads to osteoporosis and low-trauma fractures. When evaluating secondary osteoporosis analysis of calcium, phosphate and intact parathyroid hormone levels are mandatory. Osteitis fibrosa cystica and brown tumors are less frequent findings of hyperparathyroidism. However, in patients with arthritis or bone symptoms, hyperparathyroidism has to be evaluated as a possible reason. Other manifestations of hyperparathyroidism include myopathy, tendon ruptures and unspecific symptoms of the muscles and skeleton. Gout as well as pseudogout may be associated with hyperparathyroidism. Hypoparathyroidism may cause musculoskeletal diseases mimicking ankylosing spondylitis or diffuse idiopathic skeletal hyperostosis. Myopathies are sometimes induced by hypoparathyroidism. An association between systemic lupus erythematosus and hypoparathyroidism seems to exist.

Entities:  

Mesh:

Year:  2011        PMID: 21989974     DOI: 10.1007/s00393-011-0796-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  27 in total

1.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

Review 2.  Parathyroid carcinoma.

Authors:  Elizabeth A Mittendorf; Christopher R McHenry
Journal:  J Surg Oncol       Date:  2005-03-01       Impact factor: 3.454

3.  Therapeutic radiation and hyperparathyroidism. A case-control study in Rochester, Minn.

Authors:  C M Beard; H Heath; W M O'Fallon; J A Anderson; J D Earle; L J Melton
Journal:  Arch Intern Med       Date:  1989-08

4.  Primary hyperparathyroidism: clinical and biochemical features.

Authors:  L E Mallette; J P Bilezikian; D A Heath; G D Aurbach
Journal:  Medicine (Baltimore)       Date:  1974-03       Impact factor: 1.889

5.  Osteomalacic myopathy.

Authors:  J M Gilchrist
Journal:  Muscle Nerve       Date:  1995-03       Impact factor: 3.217

6.  Acute arthritis. A complication of surgically induced hypoparathyroidism.

Authors:  W V Sharp; T R Kelly
Journal:  Am J Surg       Date:  1967-06       Impact factor: 2.565

7.  Prevalence of chondrocalcinosis in patients with primary hyperparathyroidism in Japan.

Authors:  T Yashiro; T Okamoto; R Tanaka; K Ito; H Hara; T Yamashita; Y Kanaji; T Kodama; Y Ito; T Obara
Journal:  Endocrinol Jpn       Date:  1991-10

Review 8.  Secondary and tertiary hyperparathyroidism, state of the art surgical management.

Authors:  Susan C Pitt; Rebecca S Sippel; Herbert Chen
Journal:  Surg Clin North Am       Date:  2009-10       Impact factor: 2.741

9.  Incidence and location of ectopic abnormal parathyroid glands.

Authors:  Roy Phitayakorn; Christopher R McHenry
Journal:  Am J Surg       Date:  2006-03       Impact factor: 2.565

10.  Chondrocalcinosis in primary hyperparathyroidism. Influence of age, metabolic bone disease, and parathyroidectomy.

Authors:  M H Pritchard; J D Jessop
Journal:  Ann Rheum Dis       Date:  1977-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.